Chularat Hospital 미래 성장

Future 기준 확인 2/6

Chularat Hospital (는) 각각 연간 10.3% 및 7.2% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 8% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 16.4% 로 예상됩니다.

주요 정보

10.3%

수익 성장률

8.0%

EPS 성장률

Healthcare 수익 성장	10.4%
매출 성장률	7.2%
향후 자기자본 수익률	16.4%
애널리스트 커버리지	Good
마지막 업데이트	25 Nov 2024

최근 미래 성장 업데이트

Recent updates

수익 및 매출 성장 예측

SET:CHG - 애널리스트의 미래 추정치 및 과거 재무 데이터 (THB Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	10,101	1,407	1,240	1,890	8
12/31/2025	9,381	1,299	1,169	1,729	10
12/31/2024	8,460	1,121	916	1,649	6
9/30/2024	8,733	1,147	1,188	1,841	N/A
6/30/2024	8,520	1,056	932	1,841	N/A
3/31/2024	8,332	1,070	755	1,809	N/A
12/31/2023	8,014	1,046	952	2,087	N/A
9/30/2023	7,643	1,058	1,772	3,028	N/A
6/30/2023	7,574	990	1,880	2,951	N/A
3/31/2023	8,558	1,662	1,056	1,930	N/A
12/31/2022	10,408	2,778	1,806	2,629	N/A
9/30/2022	12,526	4,306	3,525	4,226	N/A
6/30/2022	14,883	5,611	3,167	3,779	N/A
3/31/2022	14,166	5,309	4,401	5,015	N/A
12/31/2021	11,999	4,204	3,522	4,005	N/A
9/30/2021	9,589	2,645	1,254	1,615	N/A
6/30/2021	6,598	1,363	1,423	1,721	N/A
3/31/2021	5,612	942	1,243	1,498	N/A
12/31/2020	5,462	877	1,004	1,298	N/A
9/30/2020	5,270	757	627	1,092	N/A
6/30/2020	5,241	744	518	1,122	N/A
3/31/2020	5,277	712	391	1,026	N/A
12/31/2019	5,188	705	241	974	N/A
9/30/2019	4,998	683	122	735	N/A
6/30/2019	4,715	565	119	715	N/A
3/31/2019	4,575	620	14	705	N/A
12/31/2018	4,427	634	45	695	N/A
9/30/2018	4,305	648	167	862	N/A
6/30/2018	4,187	665	N/A	952	N/A
3/31/2018	4,038	606	N/A	925	N/A
12/31/2017	3,894	565	N/A	910	N/A
9/30/2017	3,790	571	N/A	849	N/A
6/30/2017	3,721	563	N/A	805	N/A
3/31/2017	3,705	560	N/A	660	N/A
12/31/2016	3,655	564	N/A	705	N/A
9/30/2016	3,595	575	N/A	860	N/A
6/30/2016	3,436	536	N/A	704	N/A
3/31/2016	3,326	562	N/A	785	N/A
12/31/2015	3,171	538	N/A	698	N/A
9/30/2015	3,020	508	N/A	444	N/A
6/30/2015	2,904	514	N/A	555	N/A
3/31/2015	2,783	490	N/A	515	N/A
12/31/2014	2,695	481	N/A	446	N/A
9/30/2014	2,580	476	N/A	486	N/A
6/30/2014	2,497	475	N/A	368	N/A
3/31/2014	2,374	448	N/A	285	N/A
12/31/2013	2,234	414	N/A	309	N/A

애널리스트 미래 성장 예측

수입 대 저축률: CHG 의 연간 예상 수익 증가율( 10.3% )이 saving rate( 2% 보다 높습니다. ).

수익 vs 시장: CHG 의 연간 수익( 10.3% ) TH 시장( 17.6% 보다 느리게 성장할 것으로 예상됩니다. 17.6% 연간).

고성장 수익: CHG 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: CHG 의 수익(연간 7.2% ) TH 시장( 6.9% 보다 빠르게 성장할 것으로 예상됩니다. 6.9% 연간).

고성장 수익: CHG 의 수익(연간 7.2% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: CHG 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 16.4 %).

Chularat Hospital 미래 성장

Future 기준 확인 2/6

주요 정보

최근 미래 성장 업데이트

Consensus EPS estimates increase by 11%

Consensus EPS estimates fall by 11%

Price target decreased by 7.2% to ฿3.85

Consensus EPS estimates increase by 18%

Consensus EPS estimates increase by 27%

Consensus forecasts updated

Recent updates

Third quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Now 21% overvalued after recent price rise

First half dividend of ฿0.02 announced

Second quarter 2024 earnings: EPS misses analyst expectations

Chularat Hospital Public Company Limited Approves Interim Dividend for the Period from 1 January 2024 to 30 June 2024, Payable on September 13, 2024

First quarter 2024 earnings released: EPS: ฿0.024 (vs ฿0.022 in 1Q 2023)

Now 22% overvalued

Now 21% overvalued

Now 21% overvalued

Final dividend of ฿0.05 announced

Full year 2023 earnings: EPS misses analyst expectations

Chularat Hospital Public Company Limited, Annual General Meeting, Apr 26, 2024

Chularat Hospital Public Company Limited Approves Appointment of the Directors of Sub-Committees

Third quarter 2023 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase by 11%

Consensus EPS estimates fall by 11%

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Chularat Hospital Public Company Limited Approves an Interim Dividend for the Six-Month Period Ended 30 June 2023, Payable on 8 September 2023

Price target decreased by 7.2% to ฿3.85

First quarter 2023 earnings: EPS misses analyst expectations

Upcoming dividend of ฿0.075 per share at 4.4% yield

Less than half of directors are independent

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Chularat Hospital Public Company Limited Appoints Wandee Pisanuvanavech as Deputy Chief Executive Officer

Chularat Hospital Public Company Limited Announces Executive Changes

Upcoming dividend of ฿0.085 per share

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Chularat Hospital Public Company Limited Approves Interim Dividend for the Period from 1 January 2022 to 30 June 2022, Payable on September 9, 2022

Chularat Hospital Public Company Limited Appoints Santhat Sanguandikul as Member of the Audit Committee

Consensus EPS estimates increase by 18%

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of ฿0.17 per share

Less than half of directors are independent

Consensus EPS estimates increase by 27%

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Chularat Hospital Public Company Limited Proposes Interim Dividend, Payable on or Before May 20, 2022

Third quarter 2021 earnings released: EPS ฿0.14 (vs ฿0.026 in 3Q 2020)

Upcoming dividend of ฿0.03 per share

Consensus forecasts updated

Price target increased to ฿4.27

Chularat Hospital Public Company Limited (SET:CHG) acquired additional 10% stake in Ruampat Mae Sot International Company.

Consensus EPS estimates increase to ฿0.10

First quarter 2021 earnings released: EPS ฿0.023 (vs ฿0.017 in 1Q 2020)

Upcoming dividend of ฿0.03 per share

New 90-day high: ฿2.78

Full year 2020 earnings released: EPS ฿0.08 (vs ฿0.064 in FY 2019)

Chularat Hospital Public Company Limited, Annual General Meeting, Apr 23, 2021

New 90-day high: ฿2.74

Revenue and earnings beat expectations

Third quarter 2020 earnings released: EPS ฿0.026

Upcoming Dividend of ฿0.02 Per Share

First half earnings released

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견